About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials in Chicago | 129 Studies

Clinical Trials HIV/AIDSChicago

HIV/AIDS Clinical Trials in Chicago

Find 129 clinical trials for hiv/aids near Chicago, Illinois. Connect with research centers in your area.

All HIV/AIDS trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 129 trials

CompletedVGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2This is a phase 2, open-label efficacy study of VGX-3100 administered by intramuscular (IM) injection followed by electroporation (EP) in adult men and women who are human…NCT03499795·Chicago, Illinois and 2 others CompletedA Study of HIV and Cytomegalovirus (CMV) in HIV-Infected PatientsTo define relationships between 1) HIV load and risk of CMV disease, 2) CMV load and the risk of developing CMV disease, and 3) CMV load and HIV load.NCT00001089·Birmingham, Alabama and 35 others

HIV/AIDS Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVThe aim of this study was to assess whether TRIZIVIR, administered twice-daily was as safe, tolerable and efficacious as a combination of the drugs COMBIVIR administered…NCT00082394·Bakersfield, California and 44 others

CompletedEfficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infectionThis study will evaluate the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) administered for 12 weeks in hepatitis C…NCT02073656·Birmingham, Alabama and 40 others

CompletedEfficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 CoinfectionThe primary objectives of this study are to evaluate the efficacy, safety and tolerability of treatment with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in participants with…NCT02480712·Birmingham, Alabama and 14 others

CompletedTreatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) PatientsThe primary objective of the study is to determine if Serostim® 4 mg administered daily for 12 weeks as treatment for the abnormal fat accumulation and distribution associated…NCT00082628·Birmingham, Alabama and 30 others

CompletedA Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossTo test the hypothesis that the predominant accrual of fat rather than lean body mass (LBM) that occurs during treatment of HIV-associated wasting with megestrol acetate may be…NCT00001079·Los Angeles, California and 20 others

CompletedEvaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)The purpose of this study was to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), in adults infected…NCT02411539·San Diego, California and 12 others

CompletedCapravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing RegimenThis is a 48 week study that is intended for HIV Infected persons whose first treatment regimen was with a nonnucleoside reverse transcriptase inhibitor (NNRTI) and who are now…NCT00051844·Beverly Hills, California and 51 others

CompletedSafety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsThe purpose of this study is to compare two flu vaccines to determine their safety and ability to stimulate an immune response in HIV infected children and adolescents.NCT00091702·Birmingham, Alabama and 60 others

CompletedA Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1The purpose of the study is to provide continued access to TMC278 in HIV-1 infected patients who were randomized and treated with TMC278 in the Phase IIb or Phase III trials.NCT01266902·Beverly Hills, California and 97 others

CompletedTMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced PatientsStudy TMC114-C214 is a randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114 boosted with low dose ritonavir (RTV) versus Kaletra…NCT00110877·Phoenix, Arizona and 102 others

CompletedA Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)To compare the safety and efficacy of sevirumab (MSL 109; Protovir), human anti-cytomegalovirus (CMV) monoclonal antibody, plus active primary treatment versus placebo plus active…NCT00000836·La Jolla, California and 5 others

CompletedMyPEEPS Mobile for Young Transgender MenThe proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk…NCT05424718·Chicago, Illinois and 2 others

CompletedEmpowerment Intervention for Young Women - Phase IThis study will begin to develop a culturally appropriate secondary prevention intervention for young HIV+ women through focus groups.NCT00891358·Tampa, Florida and 2 others

CompletedSafety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and AdolescentsIntegrase is 1 of 3 HIV (Human Immunodeficiency Virus)-1 enzymes required for viral replication. Raltegravir is a drug that prevents integrase from working properly.NCT00485264·Alhambra, California and 41 others

TerminatedGW873140 In Combination With Combivir In HIV Infected SubjectsThis study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.NCT00104429·Bakersfield, California and 50 others

CompletedA Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)The purpose of this trial is to assess the non-inferior antiviral activity of GSK1349572 50 mg plus Abacavir/Lamivudine once daily versus Efavirenz/Emtricitabine/Tenofovir…NCT01263015·Hobson City, Alabama and 144 others

CompletedVaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With MalesRATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to prevent viral infection.NCT01209325·La Jolla, California and 18 others

CompletedOptimizing Kidney Transplant Informed ConsentThe objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent.NCT01859884·Birmingham, Alabama and 1 other

PreviousPage 5 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia